Revolution Medicines, Inc. (RVMD) Discusses Positive Clinical Results and Implications for Metastatic Pancreatic Cancer Treatment Transcript
Source: SeekingAlpha
2026-06-01 12:14:05 ET
Revolution Medicines, Inc. (RVMD) Discusses Positive Clinical Results and Implications for Metastatic Pancreatic Cancer Treatment May 31, 2026 7:00 PM EDT...
Read the full article on Seeking Alpha
For further details see:
Revolution Medicines, Inc. (RVMD) Discusses Positive Clinical Results and Implications for Metastatic Pancreatic Cancer Treatment Transcript
Revolution Medicines Inc - Ordinary Shares
NASDAQ: RVMD
RVMD Trading
-4.04% G/L:
$151.39 Last:
729,802 Volume:
$153.67 Open:
RVMD Latest News
June 05, 2026 03:05:00 am
Revolution Medicines Is Up 97% This Year: Here Are the Bull and Bear Cases for This Soaring Biotech Stock.
June 03, 2026 08:30:00 am
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
RVMD Stock Data
$18,541,302,498
177,467,581
0.42%
132
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
